Spinal delivery of analgesics in experimental models of pain and analgesia.
about
Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activityProstatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosineA heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers.Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neuronsThe δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptorsSumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in miceProstatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamineMouse current vocalization threshold measured with a neurospecific nociception assay: the effect of sex, morphine, and isofluraneRecombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception.Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouseThe VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivityDifferential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture.Additive antinociceptive effects of a combination of vitamin C and vitamin E after peripheral nerve injury.Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm.Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawalPhysiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of miceCentral or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathyTonic inhibition of chronic pain by neuropeptide Y.Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord.Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice.In vivo activation of the SK channel in the spinal cord reduces the NMDA receptor antagonist dose needed to produce antinociception in an inflammatory pain modelRoles of serotonergic and adrenergic receptors in the antinociception of selective cyclooxygenase-2 inhibitor in the rat spinal cordAnalgesic effects of intrathecal curcumin in the rat formalin test.Persistent Nociception Triggered by Nerve Growth Factor (NGF) Is Mediated by TRPV1 and Oxidative Mechanisms.Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.Mechanisms of G protein-coupled estrogen receptor-mediated spinal nociception.Efficacy of Intrathecal Morphine in a Model of Surgical Pain in Rats.Evaluation of the neurological safety of epidural milnacipran in ratsA Single Injection of Recombinant Adeno-Associated Virus into the Lumbar Cistern Delivers Transgene Expression Throughout the Whole Spinal Cord.Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.Enhancement of purinergic signalling by excessive endogenous ATP in resiniferatoxin (RTX) neuropathy.Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic PainBN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in miceEffects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory painDifferential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.The Role of Spinal Dopaminergic Transmission in the Analgesic Effect of Nefopam on Rat Inflammatory PainInhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain.
P2860
Q24306734-38A09F43-EF7C-4A8F-BEC0-FDBDBB7E6214Q24336492-A2D36090-FF4C-4F8C-A5F2-5CFB061E37E4Q24530081-06B890D8-5300-4770-B690-9958910EB589Q24610399-D6017029-FC7B-46C7-A904-9CD46DF93E0EQ24630886-7EF3D1A6-1CC4-4A77-AADF-FC0BE6B716A5Q27349281-1C512989-E892-488E-B615-749A5A33C22BQ28484678-69E8B2F7-007C-4F5E-B967-73EA35ECD305Q30462485-89CE8752-8633-4462-AF23-8DB743441382Q33401583-5A2BCF03-EFCD-4F1B-B6C6-107B75302D04Q33732656-86A0D2E1-B14E-46DB-AE1C-9E995D71F8C8Q33803824-55190459-FA45-4532-A1AA-8503ABDBFEF7Q33975660-304F3460-6BDF-4345-B6EA-92E93673D758Q34110860-53C2A239-D777-4DC0-B2AF-84DD74809384Q34128898-866D7E32-BA51-46A5-BA73-2693AD913E3EQ34403197-96F19569-2AF5-42B3-BFAE-5206F2322151Q34797205-3734D7C4-43E6-4E23-A338-2F56687BBBBEQ34855100-5C4B0C86-B050-4D40-B4A6-F6790817FB3AQ34881289-977F237C-9808-46B2-BA51-B76E28D92DADQ34939900-53F87395-5D22-4889-B136-CCD3355A3A73Q34939914-373E92DA-A854-4814-870F-1F09CB781F0BQ35224084-56215DB0-B3E5-4497-A03B-074182ECE559Q35597017-F984FD8C-349B-42FA-B45E-790935CC558BQ35641657-6EC697DC-28AF-463F-85EC-4056C1F06C38Q35675020-FDB7C927-646E-4AC4-AB76-3014F6BED813Q35675208-8E5BDC69-9160-4290-9F31-7477B901E371Q35731427-4CA7CDA0-1B52-4C33-8AFD-211F01F3D1CCQ36140716-D28ABFE5-0E90-420E-A053-B79AAF043E2CQ36174903-08BDEB59-CC07-45FE-8F0A-239836A023BBQ36310244-5498D58F-550E-4DFC-86A9-7BACC0EA9B3BQ36352399-F652E4C2-BB50-4930-AE20-2016149C605BQ36372689-8464E20A-429A-46EA-908B-FA567988C1D4Q36408152-3A23F9D5-0A28-4F12-BBE8-D1EC3D2B4CB1Q36470570-B94CEEC0-8EEF-4030-93A0-9CBC3FAFB30DQ36821575-594147D2-93A5-4C8B-A507-EA1AC652AFB5Q36849604-145638EE-FC38-446F-92F0-13D8D96CBDBDQ36903414-28DD15E6-1B17-4722-ABD1-92D436AA5498Q36935325-2C571059-9C5C-4EE4-8247-FBD08891EB22Q37056129-2CACA22A-9F74-4299-9801-BF16727C5479Q37089209-C5F9A8BC-7EB1-4783-A28D-C30DFD1C88EAQ37206282-8605FF92-93E3-49AC-8B6A-FAC5EE3E25C5
P2860
Spinal delivery of analgesics in experimental models of pain and analgesia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Spinal delivery of analgesics in experimental models of pain and analgesia.
@ast
Spinal delivery of analgesics in experimental models of pain and analgesia.
@en
type
label
Spinal delivery of analgesics in experimental models of pain and analgesia.
@ast
Spinal delivery of analgesics in experimental models of pain and analgesia.
@en
prefLabel
Spinal delivery of analgesics in experimental models of pain and analgesia.
@ast
Spinal delivery of analgesics in experimental models of pain and analgesia.
@en
P1476
Spinal delivery of analgesics in experimental models of pain and analgesia.
@en
P2093
Carolyn A Fairbanks
P304
P356
10.1016/S0169-409X(03)00101-7
P407
P577
2003-08-01T00:00:00Z